Informazioni
Non ci sono recensioni
Punto di Riferimento
per Medici e Operatori Sanitari
per Medici e Operatori Sanitari
LIBRERIA STUDIUM
Molecular Targeted Therapy of Lung Cancer
DISPONIBILE
Takiguchi
Editore
Springer
Anno
2017
Pagine
327
ISBN
9789811020001
DA SCONTARE
This book discusses the latest molecular targeted therapy of lung cancer including its evaluation and future directions. It clearly illustrates the initial dramatic effectiveness of molecular targeted therapy, recurrence of the disease, overcoming the wide variety of resistance mechanisms using new-generation molecular targeted agents and potential novel approaches. It also outlines the increasing necessity for new diagnostic technology and strategies for managing different adverse effects and novel methods for evaluating effectiveness and safety.
Edited and authored by opinion leaders, Molecular Targeted Therapy of Lung Cancer provides a comprehensive overview of the disease and its treatments. It is a valuable resource for graduate students, post-doctoral fellows and faculty staff, as well as researchers involved in clinical and translational research on lung cancer, helping promote new ideas for further advances.
-
Classification of Adenocarcinoma of the Lung, with a Special Reference to Prognosis
Nakatani, Yukio (et al.)
Pages 3-28
-
Screening Lung Cancer with Low-Dose CT Combined with Molecular Markers
Takiguchi, Yuichi
Pages 29-43
-
PET-CT, Bio-imaging for Predicting Prognosis and Response to Chemotherapy in Patients with Lung Cancer
Kaira, Kyoichi
Pages 45-61
-
Methods in Molecular Diagnosis
Hagiwara, Koichi
Pages 63-77
-
Accurate Nodal Staging and Biomarker Testing with Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration
Nakajima, Takahiro (et al.)
Pages 79-96
-
Next-Generation Sequencing and Bioinformatics
Kawabata-Iwakawa, Reika (et al.)
Pages 97-115
-
Companion Diagnostics
Noguchi, Emi
Pages 117-136
-
Small Cell Lung Cancer and Molecular Targeted Therapy
Iwasawa, Shunichiro
Pages 139-154
-
Locally Advanced Non-small Cell Lung Cancer and Targeted Therapy
Sekine, Ikuo
Pages 155-165
-
EGFR Mutant
Kobayashi, Kunihiko (et al.)
Pages 167-189
-
ALK Mutant
Gemma, Akihiko
Pages 191-197
-
Minor-Driver Mutant
Miyanaga, Akihiko
Pages 199-212
-
Mechanism of Resistance to Targeted Molecular Therapy
Seike, Masahiro
Pages 213-225
-
Immunotherapy
Ebata, Takahiro
Pages 227-237
-
Lung Cancer Complicated with Interstitial Lung Diseases
Minegishi, Yuji
Pages 239-252
-
Management of Adverse Effects by Molecular Targeted Therapy and Immunotherapy
Miya, Toshimichi
Pages 253-267
-
Health-Related Quality of Life in Molecular Targeted Therapy
Nakamichi, Shinji (et al.)
Pages 271-278
-
Gene Signature
Ujiie, Hideki (et al.)
Pages 279-292
-
Targeting Epithelial-Mesenchymal Transition and Cancer Stem Cell
Kurimoto, Ryota (et al.)
Pages 295-307
-
Targeting the Lung Cancer Microenvironment: Harnessing Host Responses
Fuster, Mark M.
Pages 309-327
